Mhdl Pharma (Opc) Private Limited

Founded in 2018 and headquartered in Maharashtra, India.

2018 | Thane, Maharashtra (India) | Active
Last Updated: December 08, 2024

Mhdl Pharma (Opc) Profile

Key Indicators

  • Authorised Capital ₹ 0.40 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 7 Year, 15 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth %
  • Profit Growth 15.41%
  • Ebitda 15.41%
  • Net Worth -6.77%
  • Total Assets -2.19%

About Mhdl Pharma (Opc)

Mhdl Pharma (Opc) Private Limited (MPOPL) is a Company incorporated in India on 08 February 2018 (Seven years 15 days old ). Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Business Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.

Medhavati Chaudhari serves as a director at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999MH2018OPC304949

  • Company No.

    304949

  • Incorporation Date

    08 Feb 2018

  • Date of AGM

    02 Jul 2021

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Business Services

Who are the key members and board of directors at Mhdl Pharma (Opc)?

Board Members (1)

NameDesignationAppointment DateStatus
Medhavati Chaudhari Country flag representing In Director 08-Feb-2018Current

Financial Performance of Mhdl Pharma (Opc).

Mhdl Pharma (Opc) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 15.41% increase in profit. The company's net worth dipped by a decrease of 6.77%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-2.19%
Profit or Loss
15.41%
Net Worth
-6.77%
EBITDA
15.41%

What is the Ownership and Shareholding Structure of Mhdl Pharma (Opc)?

Unlock access to Mhdl Pharma (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Mhdl Pharma (Opc)?

Unlock and access historical data on people associated with Mhdl Pharma (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mhdl Pharma (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mhdl Pharma (Opc)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Mhdl Pharma (Opc)

Recent activity within the organization

  • Balance Sheet

    Mhdl Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Annual General Meeting

    Mhdl Pharma (Opc) Private Limited last Annual general meeting of members was held on 02 Jul 2021 as per latest MCA records.

    02 Jul 2021

  • Director Appointment

    Medhavati Lokesh Chaudhari was appointed as a Director was appointed as a Director on 08 Feb 2018 & has been associated with this company since 7 years 15 days .

    08 Feb 2018

  • Company Incorporation

    Mhdl Pharma (Opc) Private Limited was registered on 08 Feb 2018 with Roc Mumbai & aged 7 years 15 days as per MCA records.

    08 Feb 2018

Frequently asked questions

  • Mhdl Pharma (Opc) Private Limited was incorporated on 08 Feb 2018.

  • The authorized share capital of Mhdl Pharma (Opc) Private Limited is ₹ 0.40 M and paid-up capital is ₹ 10.00 K .

  • Currently 1 director is associated with Mhdl Pharma (Opc) Private Limited.

    • Medhavati Lokesh Chaudhari
  • As per Ministry of Corporate Affairs (Mca), the registered address of Mhdl Pharma (Opc) Private Limited is Raj Residency 3Rd Floor Flat No. 302 Nr Anand Park, East India, Ambernath, Maharashtra, 421501.

  • The corporate identification number (CIN) of Mhdl Pharma (Opc) Private Limited is U74999MH2018OPC304949 and the company number is 304949 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2022 indicates that The net worth of Mhdl Pharma (Opc) Private Limited has experienced an downturn of -6.77%.

  • The most recent Balance Sheet for Mhdl Pharma (Opc) Private Limited was filed with the ROC on 31 Mar 2024.